Information  X 
Enter a valid email address

Okyo Pharma Limited Ord Npv (OKYO)

Date Time Source Announcement
19 Jan 2021 7:00 am
RNS
Filing patent application for the use of Chemerin
  7:00 am
GNW
OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces filing of a patent application covering the use of Chemerin and associated analogues to treat “cytokine storm” associated with COVID-19 and ARDS
14 Jan 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:37 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
07 Jan 2021 7:00 am
RNS
Directorate Change
30 Nov 2020 7:00 am
RNS
Half-year Report
14 Oct 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
13 Oct 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
09 Oct 2020 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
25 Sep 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  12:00 pm
GNW
OKYO Pharma Limited ("OKYO" or the "Company") - Result of the Annual General Meeting
  12:00 pm
RNS
Upload of Articles of Association to NSM
  12:00 pm
RNS
Notice of Results: AGM
09 Sep 2020 7:00 am
RNS
Notice of AGM
  7:00 am
GNW
Notice of Annual General Meeting
08 Sep 2020 9:17 am
RNS
Issue of convertible loan notes
21 Aug 2020 7:00 am
RNS
Grant of options - Director dealings
19 Aug 2020 7:00 am
GNW
OKYO Pharma Limited ("OKYO" or the "Company") - Appointment of Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board
  7:00 am
RNS
Dr. Napoleone Ferrara to Serve on the SAB
18 Aug 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
  7:00 am
GNW
OKYO Pharma Limited ("OKYO" or the "Company") - Issue of additional convertible loan notes to raise £1,437,104 and intention to seek dual listing on NASDAQ
  7:00 am
RNS
OKYO: CLNs to raise �1.4m, intends to list: NASDAQ
17 Aug 2020 5:00 pm
RNS
Final audited results for year ended 31 March 2020
  4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
07 Aug 2020 7:00 am
GNW
Dr James Khodabakhsh MD named Chairman of the Scientific Advisory Board at OKYO Pharma Ltd
  7:00 am
RNS
Dr James Khodabakhsh MD named Chairman of the SAB
06 Aug 2020 7:00 am
RNS
Holding(s) in Company
03 Aug 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
GNW
OKYO Pharma Limited ("OKYO" or the "Company") - Company Presentation
31 Jul 2020 4:30 pm
GNW
OKYO Pharma Limited - Upcoming Presentation
28 Jul 2020 11:14 am
GNW
OKYO Pharma Limited ("OKYO" or the "Company") - Issue of convertible loan notes to raise £3,500,000
  8:51 am
RNS
Issue of convertible loan notes
10 Jun 2020 4:42 pm
RNS
Directorate Change
05 Jun 2020 10:32 am
RNS
Notification of Major Holdings
03 Jun 2020 11:09 am
RNS
Appointment of Broker
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t